Skip to content
healthcare.dev

IBUPROFEN, DIPHENHYDRAMINE HCL

NDC 11673-225, IBUPROFEN, DIPHENHYDRAMINE HCL, capsule, liquid filled, from TARGET Corporation.

Product NDC
11673-225
Status
Listed
Labeler
TARGET Corporation
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090397
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBUPROFEN200 mg/1
  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
11673-225-15116730225151 BOTTLE in 1 CARTON (11673-225-15) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.